What's in Nephron Pharmaceuticals Corporation's pipeline?

Nephron Pharmaceuticals Corporation has 1 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Nephron Pharmaceuticals Corporation's portfolio?

Top competitors by shared drug class: Ache Laboratorios Farmaceuticos S.A., Ahn-Gook Pharmaceuticals Co.,Ltd, Ain Shams University, Beijing Tide Pharmaceutical Co., Ltd, Bioprojet.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/nephron-pharmaceuticals-corporation.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Nephron Pharmaceuticals Corporation — Portfolio Competitive Intelligence Brief

Nephron Pharmaceuticals Corporation pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
T-2345	T-2345	phase 3	ACE inhibitor	ACE	Cardiovascular

Therapeutic area mix

Cardiovascular · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Ache Laboratorios Farmaceuticos S.A. · 1 shared drug class
Ahn-Gook Pharmaceuticals Co.,Ltd · 1 shared drug class
Ain Shams University · 1 shared drug class
Beijing Tide Pharmaceutical Co., Ltd · 1 shared drug class
Bioprojet · 1 shared drug class
Boryung Pharmaceutical Co., Ltd · 1 shared drug class
Children's Hospital of Fudan University · 1 shared drug class
Ace Cells Lab Limited · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Nephron Pharmaceuticals Corporation:

Cite this brief

Drug Landscape (2026). Nephron Pharmaceuticals Corporation — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/nephron-pharmaceuticals-corporation. Accessed 2026-05-16.